Clinical Trials Logo
  1. Home
  2. Influenza
  3. NCT01984125
  4. Details
NCT01984125 Clinical Trial

Testing the Use of Prompts to Increase Adolescent Immunization Rates

Influenza Clinical Trial

— AIMHi  

Official title:
Adolescent Vaccination in the Medical Home

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01984125
Other study ID # IP000312
Secondary ID
Status Completed
Phase N/A
First received November 7, 2013
Last updated April 28, 2017
Start date April 2011
Est. completion date December 2013

Study information
Verified date April 2017
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although most US adolescents visit their primary care doctor, their immunization rates are low. Primary care practices from two networks, one in upstate New York as well as a national network of pediatric clinics were surveyed to ask what they thought was the best strategy to increase immunization rates. Point-of-care prompts (either by an electronic health record message or by a nurse) when an adolescent patient comes in for any type of visit and is due for a vaccine was chosen. This study will determine if these prompts will increase immunization rates after a 12-month intervention period.

Recruitment information / eligibility
Status Completed
Enrollment 7040
Est. completion date December 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender All
Age group 11 Years to 18 Years
Eligibility Inclusion Criteria:

- Adolescents aged 11 - 18 who had a visit to their primary care provider during the 12 month intervention period

Exclusion Criteria:

- Adolescent is pregnant during intervention time period

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Point-of-Care Prompt

Locations
Country Name City State
United States University of Michigan Ann Arbor Michigan
United States Boston Children's Boston Massachusetts
United States Oak Orchard Community Health Center Brockport New York
United States Children's Memorial Hospital - Northwestern University Chicago Illinois
United States Nationwide Children's Hospital Columbus Ohio
United States University of Florida Gainesville Florida
United States Honeoye Falls Family Medicine Honeoye Falls New York
United States Baylor College of Medicine, Texas Children's Hospital Houston Texas
United States University of Texas - Houston Houston Texas
United States University of Iowa Hospital Iowa City Iowa
United States University of Arkansas - Arkansas Children's Hospital Little Rock Arkansas
United States Mendon Pediatrics Mendon New York
United States 12 Corner Pediatrics Rochester New York
United States English Road Pediatrics Rochester New York
United States Goodman Pediatrics Rochester New York
United States Long Pond Pediatrics Rochester New York
United States Parkway Pediatrics Rochester New York
United States Ridgewood Med-Peds Rochester New York
United States Westside Pediatrics Rochester New York
United States St. Louis University - School of Medicine Saint Louis Missouri
United States University of Washington Medical Center Seattle Washington
United States Wilmington Hospital Health Center Wilmington Delaware

Sponsors (2)
Lead Sponsor Collaborator
University of California, Los Angeles Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

References & Publications (1)

Szilagyi PG, Serwint JR, Humiston SG, Rand CM, Schaffer S, Vincelli P, Dhepyasuwan N, Blumkin A, Albertin C, Curtis CR. Effect of provider prompts on adolescent immunization rates: a randomized trial. Acad Pediatr. 2015 Mar-Apr;15(2):149-57. doi: 10.1016/ — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Adolescent Immunization Rates Bivariate analysis will measure the overall change between the control and intervention groups. Vaccination rates will be summarized using descriptive statistics. As appropriate, two sample t-test or chi-square tests will be used to summarize patient level data. Odds ratio with associated 95% confidence interval will be reported within each of the 2 networks. One Year
Secondary Missed Opportunities A hierarchical logistic regression model will evaluate the intervention effect on rates of missed opportunities. One Year
See also
  Status Clinical Trial Phase
Completed NCT05523089 - The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults Phase 2
Completed NCT05009251 - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake N/A
Completed NCT03282240 - Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US Phase 3
Completed NCT00968526 - Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults Phase 3
Completed NCT00968539 - Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults Phase 3
Completed NCT00971425 - Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) Phase 3
Completed NCT05525494 - Patient Portal Flu Vaccine Reminders (5) N/A
Completed NCT04074928 - Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects Phase 3
Completed NCT04695717 - This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam Phase 3
Completed NCT05012163 - Lottery Incentive Nudges to Increase Influenza Vaccinations N/A
Completed NCT04109222 - Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively Phase 4
Completed NCT03888989 - Response to Influenza Vaccine During Pregnancy Phase 1
Completed NCT02587221 - Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age Phase 3
Completed NCT03453801 - The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Phase 1
Completed NCT01440387 - A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older Phase 3
Terminated NCT01195779 - Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children Phase 2
Completed NCT03321968 - Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults Phase 3
Completed NCT00972517 - Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children Phase 3
Completed NCT04570904 - Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Recruiting NCT03331991 - Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel N/A